EVP R&D, Chief Medical Officer
Mon, Dec 9, 2024
Dec 9
12,452 shares @ $20.03
Increased holdings by +20.80%
Net across this filing: -20.30% (-12,154 shares)
35th largest trade (out of 157)
Option Exercise
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: -20.3% (-12,154 shares)
Insider trade was 36% below market price
Price 18% above 200-day moving average